APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposome Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liposome Service Market Analysis and Forecast 2026-2032

5 March 2026205 pages

Choose your research edition.

Industry ResearchLiposome Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposome Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Liposome Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposome Service Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposome Service Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Liposome Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liposome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liposome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liposome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liposome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liposome Service include Acuitas Therapeutics, CD Bioparticles, Corden Pharma, Creative Biolabs, Creative Biostruct, Encapsula NanoSciences, Evonik, Exelead and FormuMax Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liposome Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposome Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Liposome Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposome Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposome Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liposome Service revenue, projected growth trends, production technology, application and end-user industry.

Liposome Service Segment by Company

Acuitas Therapeutics

CD Bioparticles

Corden Pharma

Creative Biolabs

Creative Biostruct

Encapsula NanoSciences

Evonik

Exelead

FormuMax Scientific

FUJIFILM Pharmaceuticals USA

GMPriority Pharma

Lipoid

LIPOSOMA

Merck KGaA

Nippon Fine Chemical

PlantaCorp

Polymun

Liposome Service Segment by Type

Liposome Development Services

Liposome Customization Service

Liposome Encapsulation Services

Others

Liposome Service Segment by Application

Pharmaceutical

Life Sciences

Cosmetics and Skin Care Industrial

Others

Liposome Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liposome Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liposome Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposome Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liposome Development Services Major Player Table 3. Liposome Customization Service Major Player Table 4. Liposome Encapsulation Services Major Player Table 5. Others Major Player Table 6. Global Liposome Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Major Player Table 8. Life Sciences Major Player Table 9. Cosmetics and Skin Care Industrial Major Player Table 10. Others Major Player Table 11. Liposome Service Industry Trends Table 12. Liposome Service Industry Drivers Table 13. Liposome Service Industry Opportunities and Challenges Table 14. Liposome Service Industry Restraints Table 15. Global Liposome Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Liposome Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Liposome Service Market Share by Region (2021-2026) Table 18. Global Liposome Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Liposome Service Market Share by Region (2027-2032) Table 20. Global Liposome Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Liposome Service Revenue Market Share by Players (2021-2026) Table 22. Global Liposome Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Liposome Service Key Players Headquarters & Area Served Table 24. Global Liposome Service Players, Product Type & Application Table 25. Global Liposome Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Liposome Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Liposome Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Liposome Service Revenue Market Share by Type (2021-2026) Table 32. Global Liposome Service Revenue Market Share by Type (2027-2032) Table 33. Global Liposome Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Liposome Service Revenue Market Share by Application (2021-2026) Table 37. Global Liposome Service Revenue Market Share by Application (2027-2032) Table 38. Acuitas Therapeutics Company Information Table 39. Acuitas Therapeutics Business Overview Table 40. Acuitas Therapeutics Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Acuitas Therapeutics Liposome Service Product Portfolio Table 42. Acuitas Therapeutics Recent Development Table 43. CD Bioparticles Company Information Table 44. CD Bioparticles Business Overview Table 45. CD Bioparticles Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. CD Bioparticles Liposome Service Product Portfolio Table 47. CD Bioparticles Recent Development Table 48. Corden Pharma Company Information Table 49. Corden Pharma Business Overview Table 50. Corden Pharma Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Corden Pharma Liposome Service Product Portfolio Table 52. Corden Pharma Recent Development Table 53. Creative Biolabs Company Information Table 54. Creative Biolabs Business Overview Table 55. Creative Biolabs Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Creative Biolabs Liposome Service Product Portfolio Table 57. Creative Biolabs Recent Development Table 58. Creative Biostruct Company Information Table 59. Creative Biostruct Business Overview Table 60. Creative Biostruct Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Creative Biostruct Liposome Service Product Portfolio Table 62. Creative Biostruct Recent Development Table 63. Encapsula NanoSciences Company Information Table 64. Encapsula NanoSciences Business Overview Table 65. Encapsula NanoSciences Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Encapsula NanoSciences Liposome Service Product Portfolio Table 67. Encapsula NanoSciences Recent Development Table 68. Evonik Company Information Table 69. Evonik Business Overview Table 70. Evonik Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Evonik Liposome Service Product Portfolio Table 72. Evonik Recent Development Table 73. Exelead Company Information Table 74. Exelead Business Overview Table 75. Exelead Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Exelead Liposome Service Product Portfolio Table 77. Exelead Recent Development Table 78. FormuMax Scientific Company Information Table 79. FormuMax Scientific Business Overview Table 80. FormuMax Scientific Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. FormuMax Scientific Liposome Service Product Portfolio Table 82. FormuMax Scientific Recent Development Table 83. FUJIFILM Pharmaceuticals USA Company Information Table 84. FUJIFILM Pharmaceuticals USA Business Overview Table 85. FUJIFILM Pharmaceuticals USA Liposome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio Table 87. FUJIFILM Pharmaceuticals USA Recent Development Table 88. GMPriority Pharma Company Information Table 89. GMPriority Pharma Business Overview Table 90. GMPriority Pharma Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. GMPriority Pharma Liposome Service Product Portfolio Table 92. GMPriority Pharma Recent Development Table 93. Lipoid Company Information Table 94. Lipoid Business Overview Table 95. Lipoid Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Lipoid Liposome Service Product Portfolio Table 97. Lipoid Recent Development Table 98. LIPOSOMA Company Information Table 99. LIPOSOMA Business Overview Table 100. LIPOSOMA Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. LIPOSOMA Liposome Service Product Portfolio Table 102. LIPOSOMA Recent Development Table 103. Merck KGaA Company Information Table 104. Merck KGaA Business Overview Table 105. Merck KGaA Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Merck KGaA Liposome Service Product Portfolio Table 107. Merck KGaA Recent Development Table 108. Nippon Fine Chemical Company Information Table 109. Nippon Fine Chemical Business Overview Table 110. Nippon Fine Chemical Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Nippon Fine Chemical Liposome Service Product Portfolio Table 112. Nippon Fine Chemical Recent Development Table 113. PlantaCorp Company Information Table 114. PlantaCorp Business Overview Table 115. PlantaCorp Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. PlantaCorp Liposome Service Product Portfolio Table 117. PlantaCorp Recent Development Table 118. Polymun Company Information Table 119. Polymun Business Overview Table 120. Polymun Liposome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Polymun Liposome Service Product Portfolio Table 122. Polymun Recent Development Table 123. North America Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Liposome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Liposome Service Revenue by Country (2021-2026) & (US$ Million) Table 129. North America Liposome Service Revenue by Country (US$ Million) & (2027-2032) Table 130. Europe Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Liposome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Liposome Service Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Liposome Service Revenue by Country (US$ Million) & (2027-2032) Table 137. China Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 138. China Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 139. China Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 140. China Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Liposome Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Liposome Service Revenue by Region (US$ Million) & (2021-2026) Table 147. Asia Liposome Service Revenue by Region (US$ Million) & (2027-2032) Table 148. SAMEA Liposome Service Revenue by Type (2021-2026) & (US$ Million) Table 149. SAMEA Liposome Service Revenue by Type (2027-2032) & (US$ Million) Table 150. SAMEA Liposome Service Revenue by Application (2021-2026) & (US$ Million) Table 151. SAMEA Liposome Service Revenue by Application (2027-2032) & (US$ Million) Table 152. SAMEA Liposome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. SAMEA Liposome Service Revenue by Country (2021-2026) & (US$ Million) Table 154. SAMEA Liposome Service Revenue by Country (US$ Million) & (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Liposome Service Image Figure 2. Global Liposome Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposome Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liposome Development Services Image Figure 5. Liposome Customization Service Image Figure 6. Liposome Encapsulation Services Image Figure 7. Others Image Figure 8. Global Liposome Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Liposome Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Image Figure 11. Life Sciences Image Figure 12. Cosmetics and Skin Care Industrial Image Figure 13. Others Image Figure 14. Global Liposome Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Liposome Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Liposome Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Liposome Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Liposome Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Liposome Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Liposome Service Revenue Market Share by Type (2021-2032) Figure 22. Global Liposome Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Liposome Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Liposome Service Revenue Market Share by Application (2021-2032) Figure 25. North America Liposome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Liposome Service Revenue Share by Type (2021-2032) Figure 27. North America Liposome Service Revenue Share by Application (2021-2032) Figure 28. North America Liposome Service Revenue Share by Country (2021-2032) Figure 29. United States Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Liposome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Liposome Service Revenue Share by Type (2021-2032) Figure 34. Europe Liposome Service Revenue Share by Application (2021-2032) Figure 35. Europe Liposome Service Revenue Share by Country (2021-2032) Figure 36. Germany Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Liposome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Liposome Service Revenue Share by Type (2021-2032) Figure 46. China Liposome Service Revenue Share by Application (2021-2032) Figure 47. Asia Liposome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Liposome Service Revenue Share by Type (2021-2032) Figure 49. Asia Liposome Service Revenue Share by Application (2021-2032) Figure 50. Asia Liposome Service Revenue Share by Region (2021-2032) Figure 51. Japan Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Liposome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Liposome Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Liposome Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Liposome Service Revenue Share by Country (2021-2032) Figure 61. Brazil Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Liposome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Liposome Development Services
  • Liposome Customization Service
  • Liposome Encapsulation Services
  • Others
Applications
  • Pharmaceutical
  • Life Sciences
  • Cosmetics and Skin Care Industrial
  • Others
Companies covered
  • Acuitas Therapeutics
  • CD Bioparticles
  • Corden Pharma
  • Creative Biolabs
  • Creative Biostruct
  • Encapsula NanoSciences
  • Evonik
  • Exelead
  • FormuMax Scientific
  • FUJIFILM Pharmaceuticals USA
  • GMPriority Pharma
  • Lipoid
  • LIPOSOMA
  • Merck KGaA
  • Nippon Fine Chemical
  • PlantaCorp
  • Polymun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposome Service Market by Type
  3. 1.2.1 Global Liposome Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liposome Development Services
  5. 1.2.3 Liposome Customization Service
  6. 1.2.4 Liposome Encapsulation Services
  7. 1.2.5 Others
  8. 1.3 Liposome Service Market by Application
  9. 1.3.1 Global Liposome Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical
  11. 1.3.3 Life Sciences
  12. 1.3.4 Cosmetics and Skin Care Industrial
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Liposome Service Market Dynamics
  1. 2.1 Liposome Service Industry Trends
  2. 2.2 Liposome Service Industry Drivers
  3. 2.3 Liposome Service Industry Opportunities and Challenges
  4. 2.4 Liposome Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liposome Service Market Perspective (2021-2032)
  2. 3.2 Global Liposome Service Growth Trends by Region
  3. 3.2.1 Global Liposome Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liposome Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Liposome Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liposome Service Revenue by Players
  2. 4.1.1 Global Liposome Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Liposome Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liposome Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liposome Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liposome Service Key Players Headquarters & Area Served
  7. 4.4 Global Liposome Service Players, Product Type & Application
  8. 4.5 Global Liposome Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liposome Service Market CR5 and HHI
  11. 4.6.3 2025 Liposome Service Tier 1, Tier 2, and Tier 3
5 Liposome Service Market Size by Type
  1. 5.1 Global Liposome Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liposome Service Revenue by Type (2021-2032)
  3. 5.3 Global Liposome Service Revenue Market Share by Type (2021-2032)
6 Liposome Service Market Size by Application
  1. 6.1 Global Liposome Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liposome Service Revenue by Application (2021-2032)
  3. 6.3 Global Liposome Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Acuitas Therapeutics
  2. 7.1.1 Acuitas Therapeutics Company Information
  3. 7.1.2 Acuitas Therapeutics Business Overview
  4. 7.1.3 Acuitas Therapeutics Liposome Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Acuitas Therapeutics Liposome Service Product Portfolio
  6. 7.1.5 Acuitas Therapeutics Recent Developments
  7. 7.2 CD Bioparticles
  8. 7.2.1 CD Bioparticles Company Information
  9. 7.2.2 CD Bioparticles Business Overview
  10. 7.2.3 CD Bioparticles Liposome Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CD Bioparticles Liposome Service Product Portfolio
  12. 7.2.5 CD Bioparticles Recent Developments
  13. 7.3 Corden Pharma
  14. 7.3.1 Corden Pharma Company Information
  15. 7.3.2 Corden Pharma Business Overview
  16. 7.3.3 Corden Pharma Liposome Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Corden Pharma Liposome Service Product Portfolio
  18. 7.3.5 Corden Pharma Recent Developments
  19. 7.4 Creative Biolabs
  20. 7.4.1 Creative Biolabs Company Information
  21. 7.4.2 Creative Biolabs Business Overview
  22. 7.4.3 Creative Biolabs Liposome Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biolabs Liposome Service Product Portfolio
  24. 7.4.5 Creative Biolabs Recent Developments
  25. 7.5 Creative Biostruct
  26. 7.5.1 Creative Biostruct Company Information
  27. 7.5.2 Creative Biostruct Business Overview
  28. 7.5.3 Creative Biostruct Liposome Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biostruct Liposome Service Product Portfolio
  30. 7.5.5 Creative Biostruct Recent Developments
  31. 7.6 Encapsula NanoSciences
  32. 7.6.1 Encapsula NanoSciences Company Information
  33. 7.6.2 Encapsula NanoSciences Business Overview
  34. 7.6.3 Encapsula NanoSciences Liposome Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Encapsula NanoSciences Liposome Service Product Portfolio
  36. 7.6.5 Encapsula NanoSciences Recent Developments
  37. 7.7 Evonik
  38. 7.7.1 Evonik Company Information
  39. 7.7.2 Evonik Business Overview
  40. 7.7.3 Evonik Liposome Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Evonik Liposome Service Product Portfolio
  42. 7.7.5 Evonik Recent Developments
  43. 7.8 Exelead
  44. 7.8.1 Exelead Company Information
  45. 7.8.2 Exelead Business Overview
  46. 7.8.3 Exelead Liposome Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Exelead Liposome Service Product Portfolio
  48. 7.8.5 Exelead Recent Developments
  49. 7.9 FormuMax Scientific
  50. 7.9.1 FormuMax Scientific Company Information
  51. 7.9.2 FormuMax Scientific Business Overview
  52. 7.9.3 FormuMax Scientific Liposome Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 FormuMax Scientific Liposome Service Product Portfolio
  54. 7.9.5 FormuMax Scientific Recent Developments
  55. 7.10 FUJIFILM Pharmaceuticals USA
  56. 7.10.1 FUJIFILM Pharmaceuticals USA Company Information
  57. 7.10.2 FUJIFILM Pharmaceuticals USA Business Overview
  58. 7.10.3 FUJIFILM Pharmaceuticals USA Liposome Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio
  60. 7.10.5 FUJIFILM Pharmaceuticals USA Recent Developments
  61. 7.11 GMPriority Pharma
  62. 7.11.1 GMPriority Pharma Company Information
  63. 7.11.2 GMPriority Pharma Business Overview
  64. 7.11.3 GMPriority Pharma Liposome Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GMPriority Pharma Liposome Service Product Portfolio
  66. 7.11.5 GMPriority Pharma Recent Developments
  67. 7.12 Lipoid
  68. 7.12.1 Lipoid Company Information
  69. 7.12.2 Lipoid Business Overview
  70. 7.12.3 Lipoid Liposome Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lipoid Liposome Service Product Portfolio
  72. 7.12.5 Lipoid Recent Developments
  73. 7.13 LIPOSOMA
  74. 7.13.1 LIPOSOMA Company Information
  75. 7.13.2 LIPOSOMA Business Overview
  76. 7.13.3 LIPOSOMA Liposome Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 LIPOSOMA Liposome Service Product Portfolio
  78. 7.13.5 LIPOSOMA Recent Developments
  79. 7.14 Merck KGaA
  80. 7.14.1 Merck KGaA Company Information
  81. 7.14.2 Merck KGaA Business Overview
  82. 7.14.3 Merck KGaA Liposome Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Merck KGaA Liposome Service Product Portfolio
  84. 7.14.5 Merck KGaA Recent Developments
  85. 7.15 Nippon Fine Chemical
  86. 7.15.1 Nippon Fine Chemical Company Information
  87. 7.15.2 Nippon Fine Chemical Business Overview
  88. 7.15.3 Nippon Fine Chemical Liposome Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Nippon Fine Chemical Liposome Service Product Portfolio
  90. 7.15.5 Nippon Fine Chemical Recent Developments
  91. 7.16 PlantaCorp
  92. 7.16.1 PlantaCorp Company Information
  93. 7.16.2 PlantaCorp Business Overview
  94. 7.16.3 PlantaCorp Liposome Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 PlantaCorp Liposome Service Product Portfolio
  96. 7.16.5 PlantaCorp Recent Developments
  97. 7.17 Polymun
  98. 7.17.1 Polymun Company Information
  99. 7.17.2 Polymun Business Overview
  100. 7.17.3 Polymun Liposome Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Polymun Liposome Service Product Portfolio
  102. 7.17.5 Polymun Recent Developments
8 North America
  1. 8.1 North America Liposome Service Revenue (2021-2032)
  2. 8.2 North America Liposome Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Liposome Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Liposome Service Revenue by Type (2027-2032)
  5. 8.3 North America Liposome Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Liposome Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Liposome Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Liposome Service Revenue by Application (2027-2032)
  9. 8.5 North America Liposome Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Liposome Service Revenue by Country
  11. 8.6.1 North America Liposome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liposome Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Liposome Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Liposome Service Revenue (2021-2032)
  2. 9.2 Europe Liposome Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liposome Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liposome Service Revenue by Type (2027-2032)
  5. 9.3 Europe Liposome Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liposome Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liposome Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liposome Service Revenue by Application (2027-2032)
  9. 9.5 Europe Liposome Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liposome Service Revenue by Country
  11. 9.6.1 Europe Liposome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liposome Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liposome Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Liposome Service Revenue (2021-2032)
  2. 10.2 China Liposome Service Revenue by Type (2021-2032)
  3. 10.2.1 China Liposome Service Revenue by Type (2021-2026)
  4. 10.2.2 China Liposome Service Revenue by Type (2027-2032)
  5. 10.3 China Liposome Service Revenue Share by Type (2021-2032)
  6. 10.4 China Liposome Service Revenue by Application (2021-2032)
  7. 10.4.1 China Liposome Service Revenue by Application (2021-2026)
  8. 10.4.2 China Liposome Service Revenue by Application (2027-2032)
  9. 10.5 China Liposome Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liposome Service Revenue (2021-2032)
  2. 11.2 Asia Liposome Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liposome Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liposome Service Revenue by Type (2027-2032)
  5. 11.3 Asia Liposome Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liposome Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liposome Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liposome Service Revenue by Application (2027-2032)
  9. 11.5 Asia Liposome Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liposome Service Revenue by Country
  11. 11.6.1 Asia Liposome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liposome Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liposome Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liposome Service Revenue (2021-2032)
  2. 12.2 SAMEA Liposome Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liposome Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liposome Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liposome Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liposome Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liposome Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liposome Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liposome Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liposome Service Revenue by Country
  11. 12.6.1 SAMEA Liposome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liposome Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liposome Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst